Table 2.
~6 months of Spaceflight + Exercise | ~10 years of Healthy Aging | |
---|---|---|
Physiological | ||
Cardiac Morphology | ↔16 or ↓15 LV mass | ↑99 LV wall thickness ↓99 LV mass |
Cardiac Function | ↔16 systolic function ↓15 diastolic function |
↔100 systolic function ↓100 diastolic function |
Cardiac Conduction | ↑8 risk of atrial fibrillation | ↑101 risk of atrial fibrillation |
Vascular Morphology | ↑102 arterial size above the heart ↑102 intima media thickness |
↑103 arterial size ↑104 intima media thickness |
Vascular Function | ↑28 arterial stiffness ↓29 jugular venous flow |
↑105 arterial stiffness ↓106 jugular venous flow |
Orthostatic Tolerance | ↔38, 39 risk of orthostatic intolerance with fluid countermeasures | ↑107 risk |
Hematological | ↓25 red blood cells | ↓108 red blood cells |
Exercise Tolerance | ↓5 peak oxygen consumption | ↓109 peak oxygen consumption |
Spaceflight Model | Aging Model | |
Biological | ||
Genomic Stability | ↑110 genomic instability | ↑111 genomic instability |
Telomere Length | ↑4 telomere length | ↓112 telomere length |
Epigenetics | ↑113 epigenetic alterations | ↑ 114epigenetic alterations |
Proteostasis | ↓115 proteostasis (↓ drosophila; ? other models) | ↓116 proteostasis |
Mitochondrial Function | ↑53 mitochondrial dysfunction | ↑117 mitochondrial dysfunction |
Cellular Division | ↑118 cellular senescence | ↑68 cellular senescence |
Stem Cell Function | ↑58 stem cell exhaustion | ↑119 stem cell exhaustion |
Intracellular Communication | ↑93 altered intercellular communication | ↑120 altered intercellular communication |